GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Respiratorius AB (XSAT:RESP) » Definitions » FCF Yield %

Respiratorius AB (XSAT:RESP) FCF Yield % : -15.86 (As of Mar. 31, 2025)


View and export this data going back to 2012. Start your Free Trial

What is Respiratorius AB FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Respiratorius AB's Trailing 12-Month Free Cash Flow is kr-5.01 Mil, and Market Cap is kr31.61 Mil. Therefore, Respiratorius AB's FCF Yield % for today is -15.86%.

The historical rank and industry rank for Respiratorius AB's FCF Yield % or its related term are showing as below:

XSAT:RESP' s FCF Yield % Range Over the Past 10 Years
Min: -24.89   Med: -3.34   Max: -0.9
Current: -15.86


During the past 13 years, the highest FCF Yield % of Respiratorius AB was -0.90%. The lowest was -24.89%. And the median was -3.34%.

XSAT:RESP's FCF Yield % is ranked worse than
51.16% of 1503 companies
in the Biotechnology industry
Industry Median: -14.97 vs XSAT:RESP: -15.86

Respiratorius AB's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.


Respiratorius AB FCF Yield % Historical Data

The historical data trend for Respiratorius AB's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Respiratorius AB FCF Yield % Chart

Respiratorius AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.42 -10.90 - -7.38 -13.87

Respiratorius AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Apr22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.32 -7.92 -16.73 -18.16 -8.36

Competitive Comparison of Respiratorius AB's FCF Yield %

For the Biotechnology subindustry, Respiratorius AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Respiratorius AB's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Respiratorius AB's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Respiratorius AB's FCF Yield % falls into.


;
;

Respiratorius AB FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Respiratorius AB's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-4.597 / 33.1435
=-13.87%

Respiratorius AB's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.693 * 4 / 33.1435
=-8.36%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Respiratorius AB FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Respiratorius AB FCF Yield % Related Terms

Thank you for viewing the detailed overview of Respiratorius AB's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Respiratorius AB Business Description

Traded in Other Exchanges
N/A
Address
Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.

Respiratorius AB Headlines

No Headlines